|
Originally published In Press as doi:10.1074/jbc.M109494200 on October 3, 2001
J. Biol. Chem., Vol. 276, Issue 49, 45862-45867, December 7, 2001
A Single Amidotransferase Forms Asparaginyl-tRNA and
Glutaminyl-tRNA in Chlamydia trachomatis*
Gregory
Raczniak §,
Hubert D.
Becker ¶,
Bokkee
Min , and
Dieter
Söll **
From the Department of Molecular Biophysics and
Biochemistry and Chemistry, Yale University,
New Haven, Connecticut 06520-8114
Received for publication, October 2, 2001
 |
ABSTRACT |
Aminoacyl-tRNA is generally formed by
aminoacyl-tRNA synthetases, a family of 20 enzymes essential for
accurate protein synthesis. However, most bacteria generate one of the
two amide aminoacyl-tRNAs, Asn-tRNA or Gln-tRNA, by transamidation of
mischarged Asp-tRNAAsn or Glu-tRNAGln
catalyzed by a heterotrimeric amidotransferase (encoded by the gatA, gatB, and gatC genes). The
Chlamydia trachomatis genome sequence reveals genes for 18 synthetases, whereas those for asparaginyl-tRNA synthetase and
glutaminyl-tRNA synthetase are absent. Yet the genome harbors three
gat genes in an operon-like arrangement
(gatCAB). We reasoned that Chlamydia uses the
gatCAB-encoded amidotransferase to generate both Asn-tRNA
and Gln-tRNA. C. trachomatis aspartyl-tRNA synthetase and
glutamyl-tRNA synthetase were shown to be non-discriminating synthetases that form the misacylated tRNAAsn and
tRNAGln species. A preparation of pure heterotrimeric
recombinant C. trachomatis amidotransferase converted
Asp-tRNAAsn and Glu-tRNAGln into Asn-tRNA and
Gln-tRNA, respectively. The enzyme used glutamine, asparagine, or
ammonia as amide donors in the presence of either ATP or GTP. These
results suggest that C. trachomatis employs the dual
specificity gatCAB-encoded amidotransferase and 18 aminoacyl-tRNA synthetases to create the complete set of 20 aminoacyl-tRNAs.
 |
INTRODUCTION |
The codons of messenger RNA are paired on the ribosome with
aminoacyl-tRNAs (AA-tRNAs)1
during the process of protein biosynthesis. Because there are 20 canonical amino acids in proteins, a corresponding set of 20 AA-tRNAs
is required. Because many organisms contain 20 aminoacyl-tRNA synthetases, each capable of acylating the cognate tRNA with the correct amino acid (1), it was believed that this is the only path to
AA-tRNA formation, as first proposed in the adaptor hypothesis (2).
However, the idea that there are 20 aminoacyl-tRNA synthetases in all
organisms has been challenged for many years beginning with the
discovery of an alternative pathway to generate Gln-tRNA (3). Initially
this was thought to be an interesting abnormality. Recent biochemical
and functional genomic studies have made it clear that the
"20-aminoacyl-tRNA synthetase rule" is preserved only in the
eukaryotic cytoplasm, whereas most organisms have less than 20 synthetases (4). The absence of glutaminyl-tRNA synthetase
(GlnRS) is by far the most common exception to the 20 aminoacyl-tRNA synthetase rule. Most bacteria and all archaea known to
date lack this enzyme. In addition, asparaginyl-tRNA synthetase (AsnRS)
is absent in many archaea and also in some bacteria. Organisms lacking
either AsnRS or GlnRS use a tRNA-dependent amino acid
transformation pathway to generate Asn-tRNA or Gln-tRNA (Fig.
1). This alternate pathway is based on
two extraordinary enzyme activities. First, it requires the presence of
two non-discriminating aminoacyl-tRNA synthetases, a glutamyl-tRNA
synthetase (GluRS) and an aspartyl-tRNA synthetase (AspRS). Such a
non-discriminating enzyme differs from the canonical synthetase by
having relaxed tRNA specificity that enables it to acylate the cognate
and a non-cognate tRNA with the cognate amino acid. For instance,
Bacillus subtilis GluRS produces Glu-tRNAGln in
addition to Glu-tRNAGlu (5). Non-discriminating AspRS
enzymes have been shown in a number of archaea and bacteria
(e.g. 6-8). Second, a tRNA-dependent amidotransferase (AdT) must amidate the mischarged aspartate or glutamate to form the correctly acylated tRNAs (6, 9-12).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
tRNA-dependent transamidation
pathway of Asn-tRNA and Gln-tRNA formation. Non-discriminating
AspRS or GluRS form Asp-tRNAAsn and
Glu-tRNAGln. The mischarged aminoacyl-tRNAs are then
transamidated to the correctly charged tRNAs by an AdT in the presence
of ATP and an amide donor.
|
|
Bacterial AdTs are, in general, heterotrimeric enzymes (10, 12, 13).
Their corresponding subunits are encoded by the gatC,
gatA, and gatB genes, which are arranged in an
operon-like manner in the chromosomes of some bacteria. Biochemical
characterization of these enzymes is still sketchy. However, the data
suggest that GatA is the AdT catalytic subunit, that GatB is involved
in recognition of the mischarged AA-tRNA, and that GatC is essential
for proper expression and/or folding of a fully active GatA protein
(10). All gatCAB-encoded bacterial AdTs studied to date are
responsible only for in vivo synthesis of one of the two
possible amide AA-tRNAs (employing Asp-AdT or Glu-AdT activity),
whereas the other amide AA-tRNA is formed by direct aminoacylation by
AsnRS or GlnRS. Looking at the available genomic sequences, 8 of 13 archaea lack both AsnRS and GlnRS but encode two different AdT enzymes
for formation of Asn-tRNA and Gln-tRNA. The discovery of an archaeal heterodimeric GatDE amidotransferase specific for Gln-tRNA formation suggests that the two amide AA-tRNA species in archaea are very likely
synthesized by two different AdTs (4). Bacterial genomes do not encode
this latter enzyme. Nevertheless, complete genomes lacking identifiable
GlnRS and AsnRS genes are known, such as Campylobacter
jejuni, all known Chlamydia strains, Helicobacter pylori, Mycobacterium tuberculosis, and
Rickettsia prowazekii (14). It has been shown in
vitro that when provided with suitable heterologous substrates,
the B. subtilis, Deinococcus radiodurans and
Thermus thermophilus GatCAB amidotransferases can synthesize both Asn-tRNA and Gln-tRNA even though they are only required to
synthesize one of these AA-tRNAs in vivo (12, 13). Using a
heterologous substrate, the Acidithiobacillus ferrooxidans
amidotransferase has been described as dual-specific. However, its
genome sequence is not yet complete; thus this organism might still
contain the canonical AsnRS or GlnRS activities, although they were not
seen in cell extracts (15). These data suggested that in organisms lacking both GlnRS and AsnRS, the gatCAB-encoded
amidotransferase is an Asp/Glu-AdT that might provide both Asn-tRNA and
Gln-tRNA for protein synthesis. Therefore, we decided to test this idea using Chlamydia trachomatis as a model. Here we report that
pure C. trachomatis amidotransferase can amidate
Chlamydia Asp-tRNAAsn and
Glu-tRNAGln generated by the homologous AspRS and GluRS
enzymes. This suggests that this single amidotransferase is responsible
for both Asn-tRNA and Gln-tRNA formation in this human pathogenic parasite.
 |
EXPERIMENTAL PROCEDURES |
General--
C. trachomatis genomic DNA was a gift of
L. Olinger (16). Oligonucleotide synthesis and DNA sequencing were
performed by the Keck Foundation Research Biotechnology Resource
Laboratory at Yale University. The pBAD expression vector was from
Invitrogen. The ceramic hydroxyapatite type I (5 ml) column was from
Bio-Rad. HiTrap heparin (5 ml) and HiTrap Q (5 ml) columns were from
Amersham Pharmacia Biotech. Cellulose thin layer chromatography plates were from Macherey-Nagel. Epicurian Coli®
BL21-CodonPlusTM competent cells were purchased from
Stratagene. Preparations of Clostridium acetobutylicum AsnRS
and AspRS2 and D. radiodurans AspRS2 were kindly given by
Benfang Ruan and Joanne Pelaschier (Yale University) and D. radiodurans GluRS and Escherichia coli GlnRS were
obtained from Dylan Chan, Hiroyuki Kobayashi, and Debra Tumbula-Hansen
(Yale University). Nucleoside triphosphates were of sequencing grade,
and HPLC analysis showed no cross-contamination.
Preparation of in Vivo Overexpressed C. trachomatis tRNA
Species--
The tRNA genes (tRNAAsp, tRNAAsn,
tRNAGlu, tRNAGln) were constructed in the
pKK223-3 vector (Amersham Pharmacia Biotech) by cassette cloning of
oligonucleotides synthesized according to the tRNA sequence and their
complement and subsequent ligation into the
HindIII-BamHI-digested vector generating
pKtRNAAsn and pKtRNAGln. Positive clones were
sequenced and used for tRNA overexpression in E. coli.
A 30-ml culture of E. coli JM105 (Amersham Pharmacia
Biotech) harboring one of the pKtRNA clones in Luria-Bertani (LB)
medium supplemented with 75 µg/ml ampicillin was incubated at
37 °C overnight and then used as inoculum for a 750-ml culture. Once
A600 of 0.5 was reached, tRNA expression was
induced by the addition of 1 mM
isopropyl-1-thio- -D-galactopyranoside, and the culture
was supplemented with 50 µg/ml ampicillin. After an 8-h incubation, cells were harvested by centrifugation at 4,000 × g
for 10 min at 4 °C and suspended in buffer A (20 mM
Tris-HCl, pH 7.4, 20 mM MgCl2, 10 mM 2-mercaptoethanol) to a final volume of 12.5 ml. Total
nucleic acids were recovered by extraction with 12.5 ml of buffer-pH
4.6-saturated phenol. After a 20-min agitation at 23 °C and 10 min
centrifugation at 4,000 × g, the aqueous phase was
removed and saved. The phenol phase was re-extracted with 12.5 ml of
buffer A. The pooled aqueous phases were extracted with an equal volume
of phenol, and the aqueous layer was recovered. DNA was partially
removed by precipitation with 20% (v/v) of 2-propanol. After
centrifugation for 15 min at 4,500 × g, the
supernatant was adjusted to 60% (v/v) of 2-propanol. The tRNA
precipitate was harvested by centrifugation for 25 min at 4,500 × g. After 1 wash the pellet was suspended in 5 ml of 200 mM Tris acetate, pH 8.5, and incubated at 37 °C for
1 h to deacylate the tRNA. The RNA was then chromatographed over
DEAE-cellulose (0.01 ml DE52/A260). The sample
was loaded onto the column and washed with several volumes of 0.01 M sodium acetate, pH 5.2, 0.2 M NaCl, 0.01 M MgCl2. The tRNA was eluted with 1 M NaCl, recovered by ethanol precipitation (10), and then
resuspended in 1.7 ml of water. The heterologous expression of the
Chlamydia tRNA genes was very good. For instance, expression
of the tRNAAsn gene gave a "total E. coli
tRNA" sample that could be aspartylated to 145 pmols/A260 compared with 25 pmols/A260 of the E. coli tRNA before
expression. Given that there are 15 pmols/A260 of E. coli tRNAAsn in the normal tRNA preparation, the
tRNAAsn in the total E. coli tRNA sample is
composed mainly of the Chlamydia species (~90%). The four
Chlamydia tRNA species relevant for this study
(tRNAAsp, tRNAAsn, tRNAGlu,
tRNAGln) were purified from the tRNA preparation after
aminoacylation and biotinylation as previously described (17).
Aminoacylation showed the individual tRNA preparations to be ~95% pure.
Construction of C. trachomatis AspRS, GluRS, and AdT
Overexpression Clones--
DNA sequences encoding the AspRS, GluRS,
and GatCAB amidotransferase as identified in the genome analysis (16)
were used to design primers for polymerase chain reaction amplification of the open reading frames (starting with ATG). After cloning the DNA
fragments into pBAD expression vectors (with or without His6 sequence) and confirmation of their sequences, the
plasmids were transformed into the E. coli BL21CodonPlusTM strain.
Overexpression and Purification of C. trachomatis
Enzymes--
The E. coli strain harboring a plasmid
containing the gatCAB operon (with a N-terminal thioredoxin
fusion for enhanced expression) was grown in a 5-liter culture. At a
cell density of A600 = 0.5, AdT expression was
induced with 0.02% (v/v) L-arabinose. After growth for
12 h, the culture was centrifuged (5 min, 4,000 × g, 4 °C) to harvest the cells (30 g), which were then
suspended in 15 ml of buffer (10 mM potassium phosphate, pH
6.8, 5 mM 2-mercaptoethanol, 0.1 mM Na-EDTA,
0.1 mM benzamidine, 10% (v/v) glycerol). After cell
disruption by sonication (15 × 20 s, 60 V) and removal of cell debris by low speed centrifugation, an S-100 fraction was prepared
(centrifugation at 100,000 × g for 1 h). All
subsequent steps were performed at 4 °C; all buffers contained 5 mM 2-mercaptoethanol, 0.1 mM Na-EDTA, 0.1 mM benzamidine, and 10% (v/v) glycerol.
The S-100 extract (30 ml) was applied to a ceramic hydroxyapatite type
I column (5 ml) equilibrated and washed with 10 mM potassium phosphate, pH 6.8. Proteins were eluted with a linear gradient (500 ml, 2.0 ml/min) of 10-50 mM potassium
phosphate, pH 6.8. Active fractions (253 ml) were pooled, dialyzed
against a solution of 10 mM NaCl, 1 mM
MgCl2, and applied to a ceramic hydroxyapatite type I
column (5 ml) equilibrated with the same buffer solution. Basic and
neutral proteins were removed by extensive washing (150 ml, 2 ml/min)
with 10 mM NaCl, 1 mM MgCl2.
Additional proteins were eliminated by washing with a linear gradient
(100 ml, 2 ml/min) of 0.001-1 M MgCl2 in 10 mM NaCl. The column was then equilibrated with 10 mM potassium phosphate, pH 6.8, and proteins were eluted
with a linear gradient (200 ml, 2 ml/min) from 10-250 mM
potassium phosphate, pH 6.8. Active fractions (110 ml) were pooled and
dialyzed against 50 mM Tris-HCl, pH 7.5 and loaded onto a
HiTrap heparin (2 × 5 ml, in series) column equilibrated with the
same buffer, and the protein was eluted with an isocratic flow (50 ml,
2 ml/min) of 100 mM KCl. Active fractions (15 ml) were
dialyzed against 50 mM Hepes-KOH, pH 7.2, and applied to a
HiTrap Q column (5 ml). Proteins were eluted with a linear gradient (100 ml, 2 ml/min) of 10-500 mM NaCl. Pure AdT fractions
(20 ml) were dialyzed against 50 mM Hepes-KOH, pH 7.2, containing 50% (v/v) glycerol and stored at 20 °C. The purity of
the enzyme was determined by SDS-PAGE and native-PAGE.
AspRS and GluRS were partially purified. These enzymes were
overexpressed in pBAD vector with or without an N-terminal
His6 tag. The His-tagged enzymes were purified on a nickel
nitrilotriacetate resin (Qiagen), whereas native enzymes were
chromatographed on Q-Sepharose (Amersham Pharmacia Biotech).
Formation of Aminoacyl-tRNA--
For amidotransferase assays, a
total of 5 nmol of unfractionated tRNA from an E. coli stain
that expresses the C. trachomatis tRNAGln or
tRNAGlu was charged with [14C]glutamate (50 µM, 260 mCi/mmol) by 4 µg of partially purified native
or His6-tagged GluRS. Charging curves were generated as described (10, 12) to check the activity with purified C. trachomatis tRNAGlu and tRNAGln expressed
in E. coli. GluRS from D. radiodurans, B. subtilis (10), and E. coli were also used. C. trachomatis tRNAAsn or tRNAAsp (4 nmol of
unfractionated tRNA from an E. coli strain expressing the
tRNA or the purified tRNAAsp and tRNAAsn
species) was charged with [14C]aspartate (50 µM, 213 mCi/mmol) by 4 µg of partially purified native
or His6-tagged C. trachomatis AspRS. AspRS from
E. coli, D. radiodurans (AspRS2), and C. acetobutylicum (AspRS2) was also used. The charging reaction was
performed at 37 °C for 30 min in a 200-µl standard reaction
mixture containing 50 mM Hepes-KOH, pH 7.2, 10 mM ATP, 25 mM KCl, 15 mM
MgCl2, 5 mM dithiothreitol. For kinetic
analyses, time points were taken in the initial velocity range in
triplicate, testing seven different concentrations of tRNA.
KM for the two tRNA substrates was calculated by non-linear regression fitting of data to the Michaelis-Menten equation.
The AA-tRNA to be used as substrate to examine the amidotransferase reaction was extracted with acid-buffered phenol followed by a chloroform extraction and an ethanol precipitation. The
[14C]AA-tRNA was dried completely and stored at
80 °C until needed.
Amidotransferase Activity Assay--
The activity assay was
adapted from previous work (10, 18). Aminoacyl-tRNA was suspended in 20 µl (2×) amidation buffer (20 mM Hepes-KOH, pH 7.2, 10 mM KCl, 2 mM dithiothreitol). The AdT was
characterized in the absence or presence of the following: 3 mM MgCl2, 2 mM NTP, 2 mM amide group donor, 0.2 mM sulfhydryl reducing reagent. An equal volume of AdT sample (0.1 nmol) was added,
and the mixture was incubated at 37 °C for 10-30 min. The reaction
was stopped by the addition of 50 µl of 0.6 M sodium acetate, pH 5.2, and followed by extraction with an equal volume of
buffer-pH 5.2-saturated phenol followed by extraction with an equal
volume of chloroform. The aqueous phase was removed, and AA-tRNA was
ethanol-precipitated and pelleted by centrifugation (15,000 × g, 4 °C, 30 min). The dried pellet was suspended in 50 µl of 25 mM KOH and incubated at 65 °C for 15 min to
deacylate the AA-tRNA. The mixture was neutralized by the addition of
1.3 µl of 100 mM HCl and then vacuum-dried. Samples were
suspended in 6 µl of double-distilled water, and a 1-µl aliquot was
spotted on a cellulose TLC plate. After chromatography in
ammonia:water:chloroform:methanol (2:1:6:6), the plate was dried at
65 °C and then exposed to an activated phosphorimaging plate for
8-12 h. [14C]Amino acids were detected by scanning the
image plate using a Fuji or Storm 860 Bioimager and analyzed with Fuji
Image Gauge V3.3 software or Molecular Dynamics ImageQuaNT V4.0.
Localization of [14C]amino acids was confirmed by
ninhydrin assay using 50 nmol of unlabeled standards.
 |
RESULTS |
C. trachomatis Has Two Non-discriminating Aminoacyl-tRNA
Synthetases--
A prerequisite of the transamidation route of
Asn-tRNA and Gln-tRNA formation is the presence of non-discriminating
AspRS and GluRS enzymes able to synthesize the mischarged tRNA
substrates for the AdT. Therefore, we cloned (based on the genome
sequence), expressed, and partially purified these enzymes, as
described under "Experimental Procedures." Both chlamydial
synthetases have comparable activity when expressed as native protein
or with the His6 tag (data not shown). Because of ease of
purification, the His6-tagged proteins were used. The
C. trachomatis genome also contains a single
tRNAAsn and a tRNAGln gene (19). These genes
were cloned and overexpressed in E. coli. The charging
efficiency of the chlamydial synthetases using the C. trachomatis tRNAAsn and tRNAGln
preparations were comparable with those obtained with the well characterized non-discriminating B. subtilis GluRS (5) and D. radiodurans AspRS2 (8) enzymes. The purified
Chlamydia tRNA species (tRNAAsp,
tRNAAsn, tRNAGlu, tRNAGln) could be
charged well with Chlamydia, E. coli,
Deinococcus, and Clostridium synthetases (see
Figs. 2, A and B,
and 3, A and B). In
addition, formation of Chlamydia Asp-tRNAAsn was
efficient when D. radiodurans AspRS2, C. acetobutylicum AspRS2, or Chlamydia AspRS were used
(Fig. 2C). Similarly, formation of Glu-tRNAGln
was accomplished by B. subtilis and Chlamydia
GluRS (Fig. 3C). Because Chlamydia AspRS does not
resemble the archaeal non-discriminating AspRS proteins (see
"Discussion"), we determined the KM for
tRNAAsp and tRNAAsn (0.95 ± 0.4 µM and 2.76 ± 0.6 µM, respectively).
These results show that the chlamydial GluRS and AspRS are
non-discriminating aminoacyl-tRNA synthetases and efficiently produce
Glu-tRNAGln and Asp-tRNAAsn.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Aminoacylation of C. trachomatis
tRNAAsp and tRNAAsn. The tRNA and
enzymes (amino acids) used are tRNAAsn with C. acetobutylicum AsnRS (Asn) ( ) and C. trachomatis
AspRS (Asp) ( ) (A), tRNAAsp with C. trachomatis AspRS (Asp) ( ) and E. coli AspRS (Asp)
( ) (B) (the activity of the C. trachomatis
AspRS in this experiment was lower than what we normally observed), and
tRNAAsn with C. trachomatis AspRS (Asp) ( ),
D. radiodurans AspRS2 (Asp) ( ), and C. acetobutylicum AspRS2 (Asp) (+) (C). The background is
the reaction without tRNA ( ).
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Aminoacylation of C. trachomatis
tRNAGlu and tRNAGln. The tRNAs
and enzymes (amino acids) used are tRNAGln with E. coli GlnRS (Gln) ( ) and C. trachomatis GluRS (Glu)
( ) (A), tRNAGlu with D. radiodurans GluRS (Glu) ( ) and C. trachomatis GluRS
(Glu) ( ) (B), and tRNAGln with B. subtilis GluRS (Glu) ( ) and C. trachomatis GluRS
(Glu) ( ) (C). The background is the reaction without tRNA
( ).
|
|
C. trachomatis GatCAB Amidotransferase Has Both Glu-AdT and Asp-AdT
Activities--
Orthologs of the three AdT-encoding genes (gatA,
gatB, and gatC) were found in the C. trachomatis genome (16). Interestingly, these genes are adjacent
and situated in an operon-like manner with the same arrangement as in
B. subtilis (10). The whole operon was cloned into an
E. coli expression vector as a thioredoxin fusion of the
gatC subunit and overexpressed, and the protein product was purified to
homogeneity. The presence of heterologous ribosomal binding sites
upstream of gatC, gatA, and gatB genes does not seem to restrict the overexpression of GatCAB, suggesting that
a chlamydial promoter region can be recognized by E. coli. Our purification procedure consisted of three chromatographic media
(hydroxyapatite, heparin-Sepharose, Q-Sepharose) and allowed purification of 8.4 mg of GatCAB from 30 g of cells with a yield of ~10% (Table I). SDS-PAGE analysis
of the purified enzyme corroborated the predicted molecular mass of the
three open reading frames, GatC 25.3 kDa (11.1 kDa GatC plus a 14.2-kDa
thioredoxin fusion protein), GatA, 55.0 kDa, and GatB 53.6 kDa (Fig.
4A). Native PAGE revealed only
one band, confirming an intact heterotrimeric enzyme (Fig.
4B). The intensity of the stain suggested an approximately equal ratio of the three subunits (Fig. 4A).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 4.
Purification of C. trachomatis
Asp/Glu-AdT. A, denaturing PAGE in a 4-20%
gradient gel containing 1% SDS. B, native PAGE in a 10%
gel. Lane 1, S-100 extract from overexpressing
E. coli strain; lane 2, pooled fractions from
first ceramic hydroxyapatite chromatography; lane 3, pooled
fractions from second ceramic hydroxyapatite chromatography; lane
4, pooled fractions from HiTrap heparin chromatography; lane
5, final fraction of pure AdT after HiTrap Q chromatography.
|
|
The purified recombinant AdT was assayed using Chlamydia
Asp-tRNAAsn and Glu-tRNAGln species (prepared
with Chlamydia AspRS and GluRS) in the presence of ATP and
the amide donor glutamine. Under our assay conditions about half of the
two different substrates was converted into the desired products with
equal efficiency (Fig. 5, lanes
2 and 4), whereas an E. coli S-100 extract
was incapable of carrying out the conversion of the mischarged AA-tRNAs
(Fig. 5, lanes 1 and 3). Additionally, removal
(with enterokinase) of the thioredoxin part of the GatC fusion protein
did not affect the Glu-AdT or Asp-AdT activities of the enzyme (data
not shown). All these results demonstrated that Chlamydia
possesses a dual specificity Asp/Glu-AdT. Together with the fact that
the organism also contains non-discriminating AspRS and GluRS enzymes,
it is likely that the dual specificity amidotransferase serves in
Asn-tRNA and Gln-tRNA formation in vivo.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 5.
Glu-AdT and Asp-AdT activities of the
C. trachomatis GatCAB enzyme. Phosphorimages of
thin-layer chromatographic separation of 14C-labeled
glutamine, glutamate, asparagine, and aspartate. For details see
"Experimental Procedures." tRNAGln is in lanes
1 and 2, and tRNAAsn is in lanes
3 and 4. Lanes 1 and 3, no AdT
but E. coli S-100. Lanes 2 and 4,
Chlamydia Asp/Glu-AdT.
|
|
Characterization of the C. trachomatis AdT--
With the
availability of pure Asp/Glu-AdT, we wanted to characterize the other
substrates of the enzyme (Table II).
Mg2+ is essential for the reaction. Amidotransferases use
various amide donors (20), predominantly glutamine, asparagine, and ammonium chloride. As can be seen in Table II, they are all active in
Asn-tRNA and Gln-tRNA formation, with ammonium chloride being less
effective. The usage is somewhat different from that of B. subtilis Glu-AdT (10); however, this will be clarified when both
enzymes are compared by detailed enzyme kinetics. On the other hand,
the utilization of nucleoside triphosphates is significantly different
by the two enzymes. Although the B. subtilis Glu-AdT can
only use ATP (10), the C. trachomatis Asp/Glu-AdT accepts GTP quite efficiently compared with ATP (Table II). In addition there
appears to be an effect of the tRNA substrate on nucleoside triphosphate use; the Chlamydia enzyme Asp-AdT activity can
also utilize CTP (Table II).
Many organisms contain tRNA-independent amidotransferases that use the
amide nitrogen of glutamine or asparagine to form ammonia as the
substrate for subsequent amination (20-23). Several of these enzymes
contain a cysteine residue in their catalytic core. To probe the role
of cysteine residues in the Chlamydia Asp/Glu-AdT, the
enzyme was incubated with the sulfhydryl reagents
N-ethylmaleimide, 5,5'-dithiobis(2-nitrobenzoic acid), and
p-hydroxy-mecuribenzoate. Because this treatment did not
affect the enzyme activity (Table II), it appears that the
solvent-exposed cysteine residues are not required for enzymatic activity.
Because Chlamydia Asp/Glu-AdT evolved to recognize two
misacylated tRNAs (tRNAAsn and tRNAGln), it was
important to check if the enzyme is able to specifically recognize only
the non-cognate amide AA-tRNA. To test this, the correctly charged
Asp-tRNAAsp and Glu-tRNAGlu were used in the
amidation reaction and found to be unsuitable substrates (Table II).
Apparent initial velocity kinetic parameters of amidation by the
chlamydial enzyme were determined under conditions of great substrate
excess relative to the enzyme. The initial velocity of Gln-tRNA
formation was 6.1 pmol/min, and Asn-tRNA formation was 3.5 pmol/min. It
appears that the rates for conversion of Glu to Gln are about twice as
fast as the rate of Asp to Asn conversion. This is consistent with the
total activity profile presented in Table I. This difference may
reflect the relative importance of Gln-tRNA formation to Asn-tRNA
formation in the cell (see "Discussion").
 |
DISCUSSION |
This is the first detailed investigation of AA-tRNA synthesis in a
genome that lacks two canonical aminoacyl-tRNA synthetases. To make up
for the lack of AsnRS and GlnRS, the non-discriminating AspRS and GluRS
enzymes and the heterotrimeric Asp/Glu-AdT constitute the
transamidation pathway for the synthesis of Asn-tRNA and Gln-tRNA in
Chlamydia. The same complement of genes is also found in the genome sequence of H. pylori (24), where knockout
experiments established the essentiality of the
amidotransferase.2 Thus,
there is a group of organisms where transamidation provides the
essential synthetic route to both amide aminoacyl-tRNAs. Although Asn-tRNA and Gln-tRNA are prerequisites for protein synthesis, under
certain metabolic situations Chlamydia may also require them
for asparagine or glutamine synthesis; the organism appears to lack the
genes encoding both asparagine synthetase and glutamine synthetase
(asnA/asnB and glnA, respectively). A similar
route to asparagine formation has been suggested for
Deinococcus and Thermus (9, 12).
Biochemical and genomic analyses have shown a great diversity of AspRS
enzymes in the living world. Sequence-based alignments reveal three
types according to their taxonomic origin (25). Bacterial-like AspRS
proteins are characterized by the presence of a C-terminal extension
and a 100-amino acid insertion domain located between the conserved
class II motifs 2 and 3. These features are missing in the archaeal and
eukaryal enzymes. A number of bacteria (e.g.
Deinococcus and Thermus AspRS2) (7, 8, 12) contain, in addition to their bacterial AspRS, a copy of an
archaeal-like AspRS able to form Asp-tRNAAsn
(i.e. non-discriminating) and significantly smaller than the bacterial-type enzyme. To date the latter enzymes are believed to be
solely discriminating. However, as show above, the C. trachomatis AspRS is a non-discriminating enzyme of the bacterial genre.
Little is known about roles of the three subunits of the GatCAB
Asp/Glu-AdT. The GatA polypeptide contains a well known amidase signature sequence (GGSSGGSAAAVSARFCPIALGSDTGGSIRQPA, positions 150-183) (26); thus, this is likely to be the catalytic subunit with
glutaminase and amidotransferase activity (10, 27). The binding of tRNA
is thought to be a property of the GatB protein, which is a member of
an isolated protein family with no known function. GatC is the most
divergent subunit for which no function can be suggested by homology
searches. It was proposed that GatC is required for proper expression
or folding of the GatA subunit (10) but appears dispensable for active
Asp-AdT purified from T. thermophilus (9). Genetic analysis
and biochemical study of partial reactions with the isolated subunits
is needed to clarify this.
What happens with the misacylated AA-tRNA? Incorrectly charged tRNA in
free form is probably detrimental to the cell because it will cause
errors in protein synthesis (28). It was shown that elongation factor
Tu from Thermus or from spinach chloroplasts has only weak
affinity for Asp-tRNAAsn or Glu-tRNAGln (9, 29)
and that this "rejection" of misacylated tRNA guarantees the
maintenance of translational fidelity. Chlamydia provides an
additional challenge to elongation factor Tu, which has to discriminate
against two different tRNAs. Although chlamydial elongation factor Tu
may be capable of doing this, there could also be another mechanism
that takes the misacylated tRNA out of circulation. Should the
non-discriminating synthetases form a complex with the Asp/Glu-AdT,
then the misacylated tRNA formed by the synthetase could be "handed
off" to the amidotransferase, thus eliminating free diffusion of this
AA-tRNA. Such a "channeling mechanism" may involve the GatC
subunit, for which there is yet no known role (30).
The intercellular physiology of Chlamydia may be tied to the
multifaceted activities of an AdT. After inoculation of host tissue
with the C. trachomatis elementary body (EB), the
environment changes to one that is depicted as hostile for invading
parasites. Bacterial infection begins a cascade of events in the body
leading to inflammation and immune response coordinated by lymphocytes, macrophages, and neutrophils. The role of glutamine utilization by
these immune cells has recently been described and reviewed (31). The
intercellular milieu surrounding the EB is depleted in glutamine and
has normal levels of glutamate, which does not affect the
internalization of the EB into the host cell since this is dependent
upon intrinsic proteins on the outer membrane of the EB and not
de novo protein synthesis (32, 33). However, once inside the
host cell, it is necessary for the parasite to express certain early
gene products to intersect an exocytic pathway avoiding lysosomal
degradation (33) and transform from the non-metabolic EB form to the
metabolically active reticulate body. It is plausible that this
glutamine-deficient parasitophorous vacuole would necessitate the
Chlamydia Asp/Glu-AdT to generate correctly charged tRNA and also supply the cell with glutamine and/or asparagine using ammonium chloride as a amide donor, since the parasite is dependent on the host
for amino acids (34) and nucleotides (35).
Detailed biochemical studies of this amidotransferase will further our
understanding of protein synthesis in this human pathogen. Because of
its unique dual tRNA specificity, this enzyme may have potential as a
species-specific therapeutic drug target.
 |
ACKNOWLEDGEMENTS |
We are most grateful to J. McCloskey and P. Crain for HPLC analysis of NTPs. We thank C. Stathopoulos, M. Ibba, and
S. Karim for critical discussions. Samples of aminoacyl-tRNA
synthetases were kindly provided by D. Chan, H. Kobayashi, J. Pelaschier, B. F. Ruan, and D. Tumbula-Hansen.
 |
FOOTNOTES |
*
Supported by a grant from the NIGMS, National Institutes of
Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
A predoctoral fellow of the Heyl Foundation. Present address:
Eastern Virginia Medical School, 721 Fairfax Avenue, Norfolk, VA
23507-2000.
¶
A European Molecular Biology postdoctoral fellow.
**
To whom correspondence should be addressed: Dept. of Molecular
Biophysics and Biochemistry, Yale University, P. O. Box 208114, 266 Whitney Ave., New Haven, CT 06520-8114. Tel.: 203-432-6200; Fax:
203-432-6202; E-mail: soll@trna.chem.yale.edu.
Published, JBC Papers in Press, October 3, 2001, DOI 10.1074/jbc.M109494200
2
A. Buhmann, D. Tumbula-Hansen, D. Söll,
and K. Melchers, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
AA-tRNA, aminoacyl-tRNA;
AdT, amidotransferase;
AsnRS, asparaginyl-tRNA
synthetase;
AspRS, aspartyl-tRNA synthetase;
GlnRS, glutaminyl-tRNA
synthetase;
GluRS, glutamyl-tRNA synthetase;
EB, elementary body;
HPLC, high performance liquid chromatography;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
| 1.
|
Ibba, M.,
and Söll, D.
(2000)
Annu. Rev. Biochem.
69,
617-650[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Crick, F. H. C.
(1958)
Symp. Soc. Exp. Biol.
12,
138-163[Medline]
[Order article via Infotrieve]
|
| 3.
|
Wilcox, M.,
and Nirenberg, M.
(1968)
Proc. Natl. Acad. Sci. U. S. A.
61,
229-236[Free Full Text]
|
| 4.
|
Tumbula, D. L.,
Becker, H. D.,
Chang, W. Z.,
and Söll, D.
(2000)
Nature
407,
106-110[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Lapointe, J.,
Duplain, L.,
and Proulx, M.
(1986)
J. Bacteriol.
165,
88-93[Abstract/Free Full Text]
|
| 6.
|
Curnow, A. W.,
Ibba, M.,
and Söll, D.
(1996)
Nature
382,
589-590[Medline]
[Order article via Infotrieve]
|
| 7.
|
Becker, H. D.,
Roy, H.,
Moulinier, L.,
Mazauric, M. H.,
Keith, G.,
and Kern, D.
(2000)
Biochemistry
39,
3216-3230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Pelaschier, J.
(2000)
Two aspartyl-tRNA synthetases in Deinococcus radioduransPh.D. thesis
, Yale University
|
| 9.
|
Becker, H. D.,
and Kern, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12832-12837[Abstract/Free Full Text]
|
| 10.
|
Curnow, A. W.,
Hong, K.,
Yuan, R.,
Kim, S.,
Martins, O.,
Winkler, W.,
Henkin, T. M.,
and Söll, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11819-11826[Abstract/Free Full Text]
|
| 11.
|
Gagnon, Y.,
Lacoste, L.,
Champagne, N.,
and Lapointe, J.
(1996)
J. Biol. Chem.
271,
14856-14863[Abstract/Free Full Text]
|
| 12.
|
Curnow, A. W.,
Tumbula, D. L.,
Pelaschier, J. T.,
Min, B.,
and Söll, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12838-12843[Abstract/Free Full Text]
|
| 13.
|
Becker, H. D.,
Min, B.,
Jacobi, C.,
Raczniak, G.,
Pelaschier, J.,
Roy, H.,
Klein, S.,
Kern, D.,
and Söll, D.
(2000)
FEBS Lett.
476,
140-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Raczniak, G.,
Ibba, M.,
and Söll, D.
(2001)
Toxicology
160,
181-189[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Salazar, J. C.,
Zúñiga, R.,
Raczniak, G.,
Becker, H.,
Söll, D.,
and Orellana, O.
(2001)
FEBS Lett.
500,
129-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Stephens, R. S.,
Kalman, S.,
Lammel, C.,
Fan, J.,
Marathe, R.,
Aravind, L.,
Mitchell, W.,
Olinger, L.,
Tatusov, R. L.,
Zhao, Q.,
Koonin, E. V.,
and Davis, R. W.
(1998)
Science
282,
754-759[Abstract/Free Full Text]
|
| 17.
|
Pütz, J.,
Wientges, J.,
Sissler, M.,
Giegé, R.,
Florentz, C.,
and Schwienhorst, A.
(1997)
Nucleic Acids Res.
25,
1862-1863[Abstract/Free Full Text]
|
| 18.
|
Jahn, D.,
Kim, Y. C.,
Ishino, Y.,
Chen, M. W.,
and Söll, D.
(1990)
J. Biol. Chem.
265,
8059-8064[Abstract/Free Full Text]
|
| 19.
|
Lowe, T. M.,
and Eddy, S. R.
(1997)
Nucleic Acids Res.
25,
955-964[Abstract/Free Full Text]
|
| 20.
|
Zalkin, H.
(1993)
Adv. Enzymol. Relat. Areas Mol. Biol.
66,
203-309[Medline]
[Order article via Infotrieve]
|
| 21.
|
Raushel, F. M.,
Thoden, J. B.,
and Holden, H. M.
(1999)
Biochemistry
38,
7891-7899[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Raushel, F. M.,
Thoden, J. B.,
Reinhart, G. D.,
and Holden, H. M.
(1998)
Curr. Opin. Chem. Biol.
2,
624-632[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Chaparian, M. G.,
and Evans, D. R.
(1991)
J. Biol. Chem.
266,
3387-3395[Abstract/Free Full Text]
|
| 24.
|
Tomb, J. F.,
White, O.,
Kerlavage, A. R.,
Clayton, R. A.,
Sutton, G. G.,
Fleischmann, R. D.,
Ketchum, K. A.,
Klenk, H. P.,
Gill, S.,
Dougherty, B. A.,
Nelson, K.,
Quackenbush, J.,
Zhou, L.,
Kirkness, E. F.,
Peterson, S.,
Loftus, B.,
Richardson, D.,
Dodson, R.,
Khalak, H. G.,
Glodek, A.,
McKenney, K.,
Fitzegerald, L. M.,
Lee, N.,
Adams, M. D.,
Hickey, E. K.,
Berg, D. E.,
Gocayne, J. D.,
Utterback, T. R.,
Peterson, J. D.,
Kelley, J. M.,
Cotton, M. D.,
Weidman, J. M.,
Fujii, C.,
Bowman, C.,
Watthey, L.,
Wallin, E.,
Hayes, W. S.,
Borodovsky, M.,
Karp, P. D.,
Smith, H. O.,
Fraser, C. M.,
and Venter, J. C.
(1997)
Nature
388,
539-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Woese, C. R.,
Olsen, G.,
Ibba, M.,
and Söll, D.
(2000)
Microbiol. Mol. Biol. Rev.
64,
202-236[Abstract/Free Full Text]
|
| 26.
|
Kobayashi, M.,
Fujiwara, Y.,
Goda, M.,
Komeda, H.,
and Shimizu, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11986-11991[Abstract/Free Full Text]
|
| 27.
|
Kobayashi, M.,
Komeda, H.,
Nagasawa, T.,
Nishiyama, M.,
Horinouchi, S.,
Beppu, T.,
Yamada, H.,
and Shimizu, S.
(1993)
Eur. J. Biochem.
217,
327-336[Medline]
[Order article via Infotrieve]
|
| 28.
|
Schimmel, P. R.,
and Söll, D.
(1979)
Annu. Rev. Biochem.
48,
601-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Stanzel, M.,
Schön, A.,
and Sprinzl, M.
(1994)
Eur. J. Biochem.
219,
435-439[Medline]
[Order article via Infotrieve]
|
| 30.
|
Srivastava, D. K.,
and Bernhard, S. A.
(1986)
Science
234,
1081-1086[Abstract/Free Full Text]
|
| 31.
|
Curi, R.,
Newsholme, P.,
Pithon-Curi, T. C.,
Pires-de-Melo, M.,
Garcia, C.,
Homem-de-Bittencourt Junior, P. I.,
and Guimaraes, A. R.
(1999)
Braz. J. Med. Biol. Res.
32,
15-21[Medline]
[Order article via Infotrieve]
|
| 32.
|
Friis, R. R.
(1972)
J. Bacteriol.
110,
706-721[Abstract/Free Full Text]
|
| 33.
|
Scidmore, M. A.,
Rockey, D. D.,
Fischer, E. R.,
Heinzen, R. A.,
and Hackstadt, T.
(1996)
Infect. Immun.
64,
5366-5372[Abstract]
|
| 34.
|
Hatch, T. P.
(1975)
Infect. Immun.
12,
211-220[Abstract/Free Full Text]
|
| 35.
|
Hatch, T. P.
(1975)
J. Bacteriol.
122,
393-400[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Luque, M. L. Riera-Alberola, A. Andujar, and J. A. G. Ochoa de Alda
Intraphylum Diversity and Complex Evolution of Cyanobacterial Aminoacyl-tRNA Synthetases
Mol. Biol. Evol.,
November 1, 2008;
25(11):
2369 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sheppard, J. Yuan, M. J. Hohn, B. Jester, K. M. Devine, and D. Soll
From one amino acid to another: tRNA-dependent amino acid biosynthesis
Nucleic Acids Res.,
April 1, 2008;
36(6):
1813 - 1825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sheppard, P.-M. Akochy, J. C. Salazar, and D. Soll
The Helicobacter pylori Amidotransferase GatCAB Is Equally Efficient in Glutamine-dependent Transamidation of Asp-tRNAAsn and Glu-tRNAGln
J. Biol. Chem.,
April 20, 2007;
282(16):
11866 - 11873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xu, J. M. Alves, T. Kitten, A. Brown, Z. Chen, L. S. Ozaki, P. Manque, X. Ge, M. G. Serrano, D. Puiu, et al.
Genome of the Opportunistic Pathogen Streptococcus sanguinis
J. Bacteriol.,
April 15, 2007;
189(8):
3166 - 3175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Deniziak, C. Sauter, H. D. Becker, C. A. Paulus, R. Giege, and D. Kern
Deinococcus glutaminyl-tRNA synthetase is a chimer between proteins from an ancient and the modern pathways of aminoacyl-tRNA formation
Nucleic Acids Res.,
March 12, 2007;
35(5):
1421 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bailly, S. Giannouli, M. Blaise, C. Stathopoulos, D. Kern, and H. D. Becker
A single tRNA base pair mediates bacterial tRNA-dependent biosynthesis of asparagine
Nucleic Acids Res.,
December 4, 2006;
34(21):
6083 - 6094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oshikane, K. Sheppard, S. Fukai, Y. Nakamura, R. Ishitani, T. Numata, R. L. Sherrer, L. Feng, E. Schmitt, M. Panvert, et al.
Structural basis of RNA-dependent recruitment of glutamine to the genetic code.
Science,
June 30, 2006;
312(5782):
1950 - 1954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sabina and D. Soll
The RNA-binding PUA Domain of Archaeal tRNA-Guanine Transglycosylase Is Not Required for Archaeosine Formation
J. Biol. Chem.,
March 17, 2006;
281(11):
6993 - 7001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bernard, P.-M. Akochy, D. Beaulieu, J. Lapointe, and P. H. Roy
Two Residues in the Anticodon Recognition Domain of the Aspartyl-tRNA Synthetase from Pseudomonas aeruginosa Are Individually Implicated in the Recognition of tRNAAsn
J. Bacteriol.,
January 1, 2006;
188(1):
269 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Salazar, A. Ambrogelly, P. F. Crain, J. A. McCloskey, and D. Soll
From The Cover: A truncated aminoacyl-tRNA synthetase modifies RNA
PNAS,
May 18, 2004;
101(20):
7536 - 7541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ibba and D. Soll
Aminoacyl-tRNAs: setting the limits of the genetic code
Genes & Dev.,
April 1, 2004;
18(7):
731 - 738.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-M. Akochy, D. Bernard, P. H. Roy, and J. Lapointe
Direct Glutaminyl-tRNA Biosynthesis and Indirect Asparaginyl-tRNA Biosynthesis in Pseudomonas aeruginosa PAO1
J. Bacteriol.,
February 1, 2004;
186(3):
767 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Salazar, I. Ahel, O. Orellana, D. Tumbula-Hansen, R. Krieger, L. Daniels, and D. Soll
Coevolution of an aminoacyl-tRNA synthetase with its tRNA substrates
PNAS,
November 25, 2003;
100(24):
13863 - 13868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brevet, J. Chen, S. Commans, C. Lazennec, S. Blanquet, and P. Plateau
Anticodon Recognition in Evolution: SWITCHING tRNA SPECIFICITY OF AN AMINOACYL-tRNA SYNTHETASE BY SITE-DIRECTED PEPTIDE TRANSPLANTATION
J. Biol. Chem.,
August 15, 2003;
278(33):
30927 - 30935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Raoult, H. Ogata, S. Audic, C. Robert, K. Suhre, M. Drancourt, and J.-M. Claverie
Tropheryma whipplei Twist: A Human Pathogenic Actinobacteria With a Reduced Genome
Genome Res.,
August 1, 2003;
13(8):
1800 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Min, M. Kitabatake, C. Polycarpo, J. Pelaschier, G. Raczniak, B. Ruan, H. Kobayashi, S. Namgoong, and D. Soll
Protein Synthesis in Escherichia coli with Mischarged tRNA
J. Bacteriol.,
June 15, 2003;
185(12):
3524 - 3526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Feng, D. Tumbula-Hansen, H. Toogood, and D. Soll
Expanding tRNA recognition of a tRNA synthetase by a single amino acid change
PNAS,
May 13, 2003;
100(10):
5676 - 5681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ryckelynck, R. Giege, and M. Frugier
Yeast tRNAAsp Charging Accuracy Is Threatened by the N-terminal Extension of Aspartyl-tRNA Synthetase
J. Biol. Chem.,
March 7, 2003;
278(11):
9683 - 9690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tumbula-Hansen, L. Feng, H. Toogood, K. O. Stetter, and D. Soll
Evolutionary Divergence of the Archaeal Aspartyl-tRNA Synthetases into Discriminating and Nondiscriminating Forms
J. Biol. Chem.,
September 27, 2002;
277(40):
37184 - 37190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Min, J. T. Pelaschier, D. E. Graham, D. Tumbula-Hansen, and D. Soll
Transfer RNA-dependent amino acid biosynthesis: An essential route to asparagine formation
PNAS,
March 5, 2002;
99(5):
2678 - 2683.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|